Gene-modified lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene-modified lymphocytes, covering 2012-08-14 to 2012-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer [Phase 2]